Enveric Biosciences, Inc. (ENVB)

NASDAQ: ENVB · IEX Real-Time Price · USD
0.182
-0.018 (-9.05%)
At close: Jun 24, 2022 4:00 PM
0.190
+0.008 (4.396%)
Pre-market: Jun 27, 2022 8:13 AM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017201620152013
Revenue
0004348.5936.1520.266.14
Revenue Growth (YoY)
----11.52%34.44%78.40%229.75%-
Cost of Revenue
00034.0138.3629.2213.395.23
Gross Profit
0008.9810.246.936.870.91
Selling, General & Admin
20.55.322.310.7918.519.365.840.28
Research & Development
4.790.17000000
Other Operating Expenses
39.340.1205.342.622.951.820
Operating Expenses
64.625.622.316.1321.1312.317.660.28
Operating Income
-64.62-5.62-2.3-7.15-10.9-5.38-0.790.63
Interest Expense / Income
0.010.450.080.730.580.750.240
Other Expense / Income
-8.20.80.032.67-00.4-0.09-0
Pretax Income
-56.43-6.86-2.41-10.55-11.47-6.53-0.940.63
Income Tax
-7.45006.35-2.39-3.75-0.130.21
Net Income
-48.98-6.86-2.41-16.9-9.07-2.78-0.810.41
Preferred Dividends
0002.582.09000
Net Income Common
-48.98-6.86-2.41-19.48-11.16-2.78-0.810.41
Shares Outstanding (Basic)
246500000
Shares Outstanding (Diluted)
246500000
Shares Change
310.48%8.82%2122.42%58.78%14.65%17.72%16848.40%-
EPS (Basic)
-2.07-1.19-0.46-81.88-75.00-21.00-7.00633.00
EPS (Diluted)
-2.07-1.19-0.46-81.88-75.00-21.00-7.00633.00
Free Cash Flow Per Share
-0.49-0.68-0.12-10.76-18.32-20.91-9.63-
Gross Margin
---20.89%21.07%19.17%33.91%14.83%
Operating Margin
----16.62%-22.42%-14.88%-3.92%10.22%
Profit Margin
----45.31%-22.97%-7.69%-4.02%6.75%
Free Cash Flow Margin
----5.95%-5.65%-7.56%-5.28%-
Effective Tax Rate
13.21%0.00%0.00%-60.18%20.86%57.41%13.63%34.00%
EBITDA
-55.74-6.3-2.33-6.92-7.67-4.42-0.54-
EBITDA Margin
----16.08%-15.79%-12.22%-2.65%-
Depreciation & Amortization
0.680.1202.93.221.360.17-
EBIT
-56.42-6.42-2.33-9.82-10.89-5.78-0.70.63
EBIT Margin
----22.84%-22.41%-15.98%-3.48%10.22%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).